Andri Sveinsson
Partner & CFO @ Novator
Ísafjörður, Iceland
Andri Sveinsson is a partner at the Novator Partners investment firm.Andri earned a master's degree in economics with a concentration on accounting from the University of Iceland. Andri’s first job in the finance and banking sector was with Skandia. He subsequently moved on to Bunadarbanki, where he was asked to serve as the director ofcorporate finance. Andri and several other colleagues then established Gilding, an investment company, which merged in 2001 with Bunadarbanki. Andri began to work alongside Thor in 2002 and was a founding partner of Novator in 2005.At Novator, Andri’s primary focus has been mergers and acquisitions, sourcing investments, finance, and operations. He has worked in several industries, most specifically in the health, telecommunications, and high-tech industries.Andri currently sits on the board and oversees investments in several companies, including SideKick Health, Catapult, Dreamlines, Xantis, Playfusion, and Nova, which are involved primarily in the fields of generic pharma, high-tech, and healthcare.Andri has many other interests, such as skiing, music, football, motorcycles, and boxing. He co-founded the Icelandic Punk Museum, which opened in 2016, and also produced several films.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Andri Sveinsson invests in
Stages Andri Sveinsson invests in
Countries Andri Sveinsson invests in
Investment Focus
Industry
- Health Care 2 (100%)
- Medical Device 2 (100%)
- Mobile 1 (50%)
- Medical 1 (50%)
- Biotechnology 1 (50%)
Stage
- Series B 1 (50%)
- Venture - Series Unknown 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Genis
|
GENIS is a biotechnology company headquartered in Siglufjörður, Iceland. They strive to discover, develop and commercialize novel and life-changing products, supplements and medical devices derived from crustacean exoskeletons. The GENIS team has been developing cutting-edge research on the production of chitin, chitosan, and short chain chitosanfor two decades. Their mission is to leverage this accumulated body of world-class scientific research with the intent of providing life-altering benefits for individuals. | $17M / Venture - Series Unknown / Dec 18, 2022 | |
Sidekick Health
|
Sidekick is a patient-centric digital care platform that is scalable across a wide range of chronic illnesses. Sidekick makes healthcare more impactful, accessible, and efficient by developing and delivering digital health products that empower patients and digitize healthcare.The Sidekick platform combines an evidence-based clinical approachwith behavioral economics and gamification. Sidekick's platform approach transforms healthcare experiences, with one platform that integrates multi-chronic condition management and personalized care experiences.Sidekick partners with international pharmaceutical companies, payers and healthcare providers, helping them to put the people they serve first. | $55M / Series B / May 05, 2022 |
Co-Investors
About Novator
Novator is an alternative investment firm founded and led by the international investor and entrepreneur Thor Bjorgolfsson.Novator's investment portfolio is focused around following sectors: Telecommunications, Pharmaceuticals, IT and Renewable Energy. In addition, Novator operates a Private Equity Fund and a Credit Opportunities Fund.Novator focuses on developing strong management teams in each of its portfolio companies. While granting them the autonomy to create value, Novator maintains a supervisory role, principally through representation on the Boards of its investee companies. Novator differentiates itself from many other private equity companies in concentrating on complex situations, either by virtue of their structure or their cross-border nature. To create value, Novator undertakes the restructuring or "de-risking" of investment opportunities through re-financing, combining acquired assets with existing businesses, through sale to strategic or financial buyers, or through flotation. Novator's investment portfolio is focused around four main sectors:Telecommunications, Pharmaceuticals, IT and Renewable Energy.
Novator Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andri Sveinsson
Partner & CFO
|
|||
Anna-Kreeta Rantamaa-Hiltunen
Director
|
|||
Birgir Ragnarsson
Managing Partner
|
|||
Chiehmi Chan
Partner
|
|||
Hasan Qureshi
Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Andri Sveinsson invest in?
Andri Sveinsson invests primarily in Health Care, Medical Device and Mobile startups, most often at Series B and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Iceland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andri Sveinsson last invest?
The most recent investment recorded for Andri Sveinsson closed in Dec 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
